Rivino L - Search Results

1

Metformin as adjunctive therapy for dengue in overweight and obese patients: a protocol for an open-label clinical trial (MeDO).

Nguyen NM, Chanh HQ, Tam DTH, Vuong NL, Chau NTX, Chau NVV, Phong NT, Trieu HT, Luong Thi Hue T, Cao Thi T, Dinh The T, Duyen HTL, Van NTT, Nguyen Than Ha Q, Rivino L, Gallagher P, Jones NK, Geskus RB, Kestelyn E, Yacoub S. Nguyen NM, et al. Among authors: rivino l. Wellcome Open Res. 2021 Feb 8;5:160. doi: 10.12688/wellcomeopenres.16053.2. eCollection 2020. Wellcome Open Res. 2021. PMID: 33083561 Free PMC article.

2

Dengue: Status of current and under-development vaccines.

Redoni M, Yacoub S, Rivino L, Giacobbe DR, Luzzati R, Di Bella S. Redoni M, et al. Among authors: rivino l. Rev Med Virol. 2020 Jul;30(4):e2101. doi: 10.1002/rmv.2101. Epub 2020 Feb 26. Rev Med Virol. 2020. PMID: 32101634 Free article. Review.

3

The association of obesity and severe dengue: possible pathophysiological mechanisms.

Gallagher P, Chan KR, Rivino L, Yacoub S. Gallagher P, et al. Among authors: rivino l. J Infect. 2020 Jul;81(1):10-16. doi: 10.1016/j.jinf.2020.04.039. Epub 2020 May 12. J Infect. 2020. PMID: 32413364 Review.

4

Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?

McBride A, Mehta P, Rivino L, Ramanan AV, Yacoub S. McBride A, et al. Among authors: rivino l. Lancet Microbe. 2021 Jul;2(7):e277-e278. doi: 10.1016/S2666-5247(21)00087-2. Epub 2021 Apr 20. Lancet Microbe. 2021. PMID: 33899037 Free PMC article. No abstract available.

5

Hyperinflammatory Syndrome, Natural Killer Cell Function, and Genetic Polymorphisms in the Pathogenesis of Severe Dengue.

Vuong NL, Cheung KW, Periaswamy B, Vi TT, Duyen HTL, Leong YS, Binte Hamis ZN, Gregorova M, Ooi EE, Sessions O, Rivino L, Yacoub S. Vuong NL, et al. Among authors: rivino l. J Infect Dis. 2022 Oct 17;226(8):1338-1347. doi: 10.1093/infdis/jiac093. J Infect Dis. 2022. PMID: 35267010 Free PMC article.

6

T cell immunity to dengue virus and implications for vaccine design.

Rivino L. Rivino L. Expert Rev Vaccines. 2016;15(4):443-53. doi: 10.1586/14760584.2016.1116948. Epub 2015 Nov 27. Expert Rev Vaccines. 2016. PMID: 26560171 Free article. Review.

7

Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.

Lim MQ, Kumaran EAP, Tan HC, Lye DC, Leo YS, Ooi EE, MacAry PA, Bertoletti A, Rivino L. Lim MQ, et al. Among authors: rivino l. Front Immunol. 2018 Oct 1;9:2225. doi: 10.3389/fimmu.2018.02225. eCollection 2018. Front Immunol. 2018. PMID: 30327651 Free PMC article.

8

Live vaccine infection burden elicits adaptive humoral and cellular immunity required to prevent Zika virus infection.

Yau C, Gan ES, Kwek SS, Tan HC, Ong EZ, Hamis NZ, Rivino L, Chan KR, Watanabe S, Vasudevan SG, Ooi EE. Yau C, et al. Among authors: rivino l. EBioMedicine. 2020 Nov;61:103028. doi: 10.1016/j.ebiom.2020.103028. Epub 2020 Oct 9. EBioMedicine. 2020. PMID: 33045466 Free PMC article.

9

Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.

Watanabe S, Chan KW, Wang J, Rivino L, Lok SM, Vasudevan SG. Watanabe S, et al. Among authors: rivino l. J Virol. 2015 Jun;89(11):5847-61. doi: 10.1128/JVI.00216-15. Epub 2015 Mar 18. J Virol. 2015. PMID: 25787279 Free PMC article.

10

CD4⁺ and CD8⁺ T-cell immunity to Dengue - lessons for the study of Zika virus.

Rivino L, Lim MQ. Rivino L, et al. Immunology. 2017 Feb;150(2):146-154. doi: 10.1111/imm.12681. Epub 2016 Nov 27. Immunology. 2017. PMID: 27763656 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters